HomeTherapy AreasProductsManufacturingCareerNewsContact
onlinemarketinghIgeoQjSiEunsplash_57hsg_3072
Therapy Area — Men's Health

Men's Health

Inspiron Scientific delivers a comprehensive portfolio of evidence-based therapeutics addressing erectile dysfunction, testosterone deficiency, male infertility, sexual wellness, and holistic men's urological health.

doctormalereproductivesystemanatomy260nw2800243747_3l33w_591
12+
Products in Portfolio
◆ Clinical Excellence in Men's Health

Comprehensive Men's Health Therapeutics

Men's Health within urology encompasses a broad clinical spectrum — from erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) to testosterone deficiency syndrome (TDS), male infertility, and premature ejaculation. As urologists and andrologists, understanding the interconnected pathophysiology of these conditions is critical for delivering guideline-directed, patient-centered therapy.

Inspiron Scientific's Men's Health portfolio is strategically formulated to cover key pharmacological classes: PDE5 inhibitors (Tadalafil), selective alpha-1A adrenoceptor blockers (Silodosin, Tamsulosin), 5-alpha-reductase inhibitors (Dutasteride), nitric oxide precursors (L-Arginine), and combination therapies that address comorbid LUTS/BPH with sexual dysfunction.

Pathophysiology of ED
Erectile dysfunction results from impaired nitric oxide (NO)–cGMP signaling in cavernosal smooth muscle. Endothelial dysfunction, often secondary to diabetes, hypertension, or dyslipidemia, reduces NO bioavailability. PDE5 inhibitors like Tadalafil enhance the NO–cGMP pathway, providing sustained erections. Tadalafil's 17.5-hour half-life allows daily low-dose (5mg) therapy with concomitant LUTS/BPH benefit.
Testosterone Deficiency Syndrome
Late-onset hypogonadism (LOH) is diagnosed when total testosterone falls below 300 ng/dL with associated symptoms: reduced libido, fatigue, depressed mood, decreased muscle mass, and metabolic syndrome. Assessment should include morning total/free testosterone, LH, FSH, and SHBG levels. L-Arginine supplementation supports endogenous NO production, complementing hormonal optimization strategies.
BPH & Sexual Dysfunction Nexus
BPH and ED share common pathophysiological pathways including Rho-kinase/endothelin-mediated smooth muscle contraction, pelvic atherosclerosis, and autonomic nervous system overactivity. Combination therapy with Tamsulosin + Tadalafil addresses both LUTS and erectile dysfunction simultaneously, improving IPSS scores while restoring erectile function. This dual-action approach reduces polypharmacy burden.
Male Infertility Assessment
Male factor infertility contributes to ~50% of infertile couples. Semen analysis (WHO 2021 criteria) is the cornerstone investigation. Oxidative stress-induced sperm DNA fragmentation can be mitigated with antioxidant supplementation including L-Arginine and L-Carnitine. Hormonal evaluation (FSH, LH, testosterone, prolactin) and scrotal ultrasound guide targeted management strategies.
Premature Ejaculation (PE)
PE affects approximately 20–30% of men and is classified as lifelong or acquired. Intravaginal ejaculatory latency time (IELT) <3 minutes with poor control constitutes clinical PE. Serotonergic pathways play a central role. SSRIs (off-label) and topical anesthetics are first-line pharmacotherapy. Behavioral techniques including the stop-start method and squeeze technique complement pharmacological management.
Cardiovascular Risk & ED
ED is increasingly recognized as a sentinel marker for cardiovascular disease (CVD), often preceding coronary events by 3–5 years. The Princeton III Consensus guidelines recommend cardiovascular risk stratification in all ED patients. Shared risk factors include endothelial dysfunction, diabetes, hypertension, and dyslipidemia. PDE5 inhibitors are contraindicated with nitrates; exercise stress testing may be warranted in intermediate-risk patients.
● Clinical Focus Areas

Key Men's Health Conditions
We Address

Our portfolio is strategically designed to address the most prevalent men's health conditions, providing clinicians with reliable, evidence-based therapeutic options.

Erectile Dysfunction (ED)

40-70% Men Aged 40-70

ED is often a sentinel marker for underlying cardiovascular disease, sharing common pathophysiological pathways involving endothelial dysfunction and impaired NO–cGMP signaling. Comprehensive evaluation including cardiovascular risk assessment (Princeton III guidelines) is essential. PDE5 inhibitors like Tadalafil are first-line therapy, offering both on-demand and daily dosing options. Tadalafil's extended half-life (17.5h) provides a wider therapeutic window and concomitant LUTS/BPH benefit.

Benign Prostatic Hyperplasia (BPH)

High Prevalence >50 years

BPH affects approximately 50% of men by age 50 and up to 80% by age 80. Progressive prostate enlargement leads to LUTS including weak stream, hesitancy, frequency, urgency, and nocturia. IPSS scoring guides severity-based management. Selective alpha-1A blockers (Silodosin, Tamsulosin) provide rapid symptom relief, while combination therapy with 5-alpha-reductase inhibitors (Dutasteride) is recommended for moderate-to-severe cases with enlarged prostates to reduce progression risk.

Testosterone Deficiency Syndrome

Growing Clinical Need

Late-onset hypogonadism (LOH) and testosterone deficiency syndrome impact metabolic health, mood, sexual function, bone density, and overall vitality. Comprehensive evaluation including serum testosterone (total and free), LH, FSH, and SHBG levels guides diagnosis. Threshold: total testosterone <300 ng/dL with symptoms. Evidence-based supplementation with L-Arginine supports nitric oxide-mediated vasodilation, improving endothelial function and complementing hormonal support therapies.

Male Infertility

~50% of Infertile Couples

Male factor infertility contributes to approximately 50% of infertile couples. Semen analysis per WHO 2021 criteria is the cornerstone investigation. Key parameters include sperm concentration (≥16 million/mL), total motility (≥42%), and normal morphology (≥4%). Oxidative stress-induced sperm DNA fragmentation is increasingly recognized as a significant factor. Antioxidant supplementation with L-Arginine, L-Carnitine, and micronutrients can improve semen parameters and reduce oxidative damage.

Premature Ejaculation (PE)

20-30% Male Prevalence

Premature ejaculation is the most common male sexual dysfunction, classified as lifelong or acquired. Diagnosis is based on IELT <3 minutes, poor ejaculatory control, and associated psychological distress. Serotonergic dysregulation plays a central pathophysiological role. Management combines behavioral techniques (stop-start method, squeeze technique) with pharmacotherapy. SSRIs, topical anesthetics, and PDE5 inhibitors (in comorbid ED) form the therapeutic armamentarium.

Coexistent BPH/LUTS & ED

Dual Pathology Management

BPH/LUTS and ED frequently coexist, sharing common pathophysiological mechanisms including pelvic atherosclerosis, Rho-kinase activation, autonomic overactivity, and NO/cGMP pathway impairment. Fixed-dose combination therapy with Tamsulosin + Tadalafil provides synergistic benefit — alpha-blockade for LUTS symptom relief coupled with PDE5 inhibition for erectile function restoration. This dual-action approach reduces polypharmacy and improves medication adherence while addressing both conditions simultaneously.

● Our Men's Health Portfolio

Therapeutic Products
for Men's Health

A curated portfolio of WHO-GMP certified pharmaceutical products designed to address the full spectrum of men's health and urological conditions.

Edja MD
Tadalafil

PDE5 inhibitor for erectile dysfunction with extended duration of action (17.5h half-life). Available in on-demand and daily low-dose options for ED and LUTS/BPH symptom relief.

Tamgo-T
Tamsulosin + Tadalafil

Dual-action therapy addressing coexistent BPH/LUTS and erectile dysfunction. Synergistic benefit through complementary alpha-blockade and PDE5 inhibition mechanisms.

Argixamen
L-Arginine Based

Nitric oxide precursor supplement supporting endothelial function, male reproductive health, improved semen parameters, and overall vascular wellness.

Silgo-8
Silodosin 8mg

Selective alpha-1A adrenoceptor blocker for BPH-associated LUTS. Superior uroselective profile with rapid onset of symptom relief and minimal cardiovascular effects.

Silgo-D8
Silodosin + Dutasteride

Combination therapy for moderate-to-severe BPH. Dual mechanism addresses both smooth muscle tone and prostatic volume reduction for long-term management.

Tamgo / Tamgo Plus
Tamsulosin HCl / Tamsulosin + Dutasteride

Alpha-1A selective blockers for BPH-related LUTS. Tamgo Plus provides fixed-dose combination for long-term BPH management with reduced progression risk.

● Patient Education

Understanding Men's Health

Empowering men with knowledge to recognize symptoms early, break the stigma around men's health issues, seek timely intervention, and adopt proactive lifestyle measures for better outcomes.

Warning Signs to Watch

Men should be aware of these key symptoms:

  • Difficulty achieving or maintaining an erection
  • Reduced sexual desire or libido
  • Frequent urination, especially at night (nocturia)
  • Weak or interrupted urine stream
  • Persistent fatigue, mood changes, or irritability
  • Decreased muscle mass or unexplained weight gain
  • Difficulty with fertility or changes in ejaculation

When to See a Specialist

Consult a urologist or andrologist if you experience:

  • Erectile difficulties lasting more than a few weeks
  • Recurrent or persistent urinary symptoms
  • Concerns about testosterone levels or hormonal health
  • Difficulty conceiving after 12 months of trying
  • Premature ejaculation causing relationship distress
  • Family history of prostate disease
  • Any changes in sexual or urinary function after age 40

Prevention & Lifestyle

Adopt these habits for better men's health:

  • Exercise regularly — 150 min/week of moderate activity
  • Maintain a healthy weight (BMI < 25)
  • Follow a heart-healthy diet rich in fruits & vegetables
  • Limit alcohol consumption and quit smoking
  • Manage stress through mindfulness or counseling
  • Practice pelvic floor exercises (Kegels)
  • Get adequate sleep (7–8 hours nightly)
  • Schedule annual health screenings after 40

Your Treatment Journey

What to expect from modern men's health care:

  • Confidential, non-judgmental clinical evaluation
  • Comprehensive diagnostic workup & blood tests
  • Personalized medication therapy plans
  • Combination therapies for multi-symptom relief
  • Lifestyle counseling & nutritional guidance
  • Regular follow-up monitoring & dose optimization
  • Mental health support & relationship counseling
  • Access to advanced treatments & specialist referrals
● Growth Roadmap

Future Specialties Expansion

Our strategic roadmap for expanding into new therapeutic areas to serve more patients and healthcare needs.

Dermatology
Dermatology
Coming Soon
Nephrology
Nephrology
Coming Soon
Oncology
Oncology
Coming Soon
Women's Health
Women's Health
Coming Soon
● Connect With Us

Ready to Partner
With Inspiron Scientific?

Whether you're a healthcare provider seeking quality pharmaceutical products, a distributor exploring partnership opportunities, or a professional looking to join our team — we'd love to hear from you.

● Get in Touch

Connect With Inspiron Scientific

Our team is available to discuss how Inspiron Scientific can support your healthcare needs. Reach out today.

Corporate Office
Inspiron Scientific Pvt. Ltd.,
AIMS, Ponekara (P.O.),
PIN – 682041, Kochi, Kerala
Warehouse
Inspiron Scientific Pvt. Ltd.,
Door No. 37/558-P, Q, R, N,
Near Govt. Ayurveda Hospital,
Mullampara, Manjeri (P.O.) – 676121, Kerala
Email
Inspironscientific@gmail.com
Contact Number
+91 86061 09910
Business Hours
Monday – Saturday
9:00 AM – 7:00 PM IST

Enquiry Form

Fill out the form below and our team will contact you promptly.

Quality Guarantee

Our Quality Commitment

At Inspiron Scientific, quality is non-negotiable. Every product in our portfolio is sourced from WHO-GMP certified manufacturing partners and undergoes rigorous quality assurance processes. We stand behind the safety, efficacy, and consistency of every medicine we deliver.

✓ WHO-GMP Certified✓ ISO 9001:2015✓ Regulatory Compliant✓ Batch Tested